Omnicell (OMCL) Tops Q2 EPS by 7c, Revenues In-Line; Offers FY18 Revenue Guidance Below Consensus

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. META
3. ABBV
4. SPY
5. FDX
6. IBM
7. MU
8. PFE
9. AWK
10. ACN

Go back to Omnicell (OMCL) Tops Q2 EPS by 7c, Revenues In-Line; Offers FY18 Revenue Guidance Below Consensus

Omnicell Announces Second Quarter 2018 Results

July 26, 2018 4:01 PM EDT

MOUNTAIN VIEW, Calif., July 26, 2018 /PRNewswire/ -- Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication and supply management solutions to healthcare systems, today announced results for its second quarter ended June 30, 2018.

GAAP Results

GAAP revenues for the second quarter of 2018 were $188.7 million, up $7.6 million, or 4.2% from the second quarter of 2017. GAAP... More